Rekombinanter Hemagglutinin Antikörper

Produktnummer ABIN7482212

Der Human Monoklonal anti-Hemagglutinin Antikörper wird verwendet zum Nachweis von Hemagglutinin in Proben von Influenza A Virus H1N1. Er wurde validiert für ELISA.

Kurzübersicht für Rekombinanter Hemagglutinin Antikörper (ABIN7482212)

Target: Hemagglutinin (HA)

Antikörpertyp: Recombinant Antibody

Reaktivität: Influenza A Virus H1N1

Wirt: Human

Klonalität: Monoklonal

Konjugat: Dieser Hemagglutinin Antikörper ist unkonjugiert

Applikation: ELISA

Klon: 6D1

Produktdetails anti-Hemagglutinin Antikörper

Verwendungszweck: Monoclonal Anti-HA (A/Wisconsin/588/2019 (H1N1)) Antibody, Human IgG1 (6D1)

Isotyp: IgG1

Anwendungsinformationen

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Lagerung: -20 °C

Details zu Hemagglutinin

Target: Hemagglutinin (HA)

Substanzklasse: Influenza Protein

Hintergrund: Influenza, commonly known as 'the flu', is an infectious disease of birds and mammals caused by RNA viruses of the family Orthomyxoviridae, the influenza viruses. The virus is divided into three main types (Influenzavirus A, Influenzavirus B, and Influenzavirus C), which are distinguished by differences in two major internal proteins (hemagglutinin (HA) and neuraminidase (NA), which are the most important targets for the immune system. Hemagglutinin binds to the sialic acid-containing receptors on the surface of host cells during initial infection and at the end of an infectious cycle which makes it a great target for vaccine studies.